| (SEK) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 254.52M | — |
| Operating expense | — | — |
| Net income | 20.85M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, SUS.ST returned -53.2% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +52.1% |
| 1 year | -53.2% |
| 5 years | -81.9% |
| All-time high | kr 292.00 (Nov 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what kr1,000 in SUS.ST would be worth today ›No. Surgical Science Sweden AB (publ) has not paid a dividend in the past 12 months.
Surgical Science Sweden AB (publ) is part of the Healthcare sector.
Surgical Science Sweden AB (publ) has a market cap of 2.52B SEK, based on the latest quote.
Surgical Science Sweden AB (publ) is scheduled to report earnings on Nov 12, 2026.